HIV and COVID-19 – What We’ve Learned

What exactly makes a paper a good fit for the Journal of Infectious Diseases? JID Editor-in-Chief and Professor of Medicine, Oncology and Molecular Microbiology and Immunology at the Johns Hopkins University School of Medicine, Cynthia Sears, MD, FIDSA, and JID Deputy Editor and ...  Afficher plus

Meet the newest voices behind Let’s Talk ID. Infectious disease physicians Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM, FSHEA, and Nico Cortes-Penfield, MD, FACP, FIDSA, join the podcast as co-hosts for episodes focused on research published in IDSA journals. In their first episode, ...  Afficher plus

Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ...  Afficher plus

For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company Americ ...  Afficher plus

Three members of President Biden's former COVID-19 Advisory Board—Luciana Borio, MD, Ezekiel Emanuel, MD, PhD, and Mike Osterholm, PhD—discuss their recent JAMA Viewpoints, providing their ideas on strategies for public health as COVID-19 transitions from pandemic to endemic. ...

In this episode I cover HIV.

If you want to follow along with written notes on HIV go to https://zerotofinals.com/medicine/infectiousdisease/hiv/ or the infectious diseases section in the Zero to F ...